Literature DB >> 11796230

Telomerase in cancer and aging.

Meaghan P Granger1, Woodring E Wright, Jerry W Shay.   

Abstract

The telomere-telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level, which may either delay or hasten this arrest. As humans age, a particular concern is the accumulation of events that lead to the progression of cancer. Telomerase is a mechanism that most normal cells do not possess, but almost all cancer cells acquire, to overcome their mortality and extend their lifespan. This review aims to provide a comprehensive understanding of the role of telomerase in cancer development, progression, diagnosis, and in the future, treatment. The ultimate goal of telomerase research is to use our understanding to develop anti-telomerase therapies, an almost universal tumor target.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796230     DOI: 10.1016/s1040-8428(01)00188-3

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  30 in total

1.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Authors:  Sheila A Stewart; William C Hahn; Benjamin F O'Connor; Elisa N Banner; Ante S Lundberg; Poonam Modha; Hana Mizuno; Mary W Brooks; Mark Fleming; Drazen B Zimonjic; Nicholas C Popescu; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

2.  The solution structure of an essential stem-loop of human telomerase RNA.

Authors:  Thomas Leeper; Nicolas Leulliot; Gabriele Varani
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

3.  Reverse transcriptase at bacterial telomeres.

Authors:  Neal F Lue; Sulin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-28       Impact factor: 11.205

4.  Telomerase can act as a template- and RNA-independent terminal transferase.

Authors:  Neal F Lue; Dimitry Bosoy; Tara J Moriarty; Chantal Autexier; Brian Altman; Siyang Leng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

5.  Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.

Authors:  Qing-You Du; Xiao-Bo Wang; Xue-Jun Chen; Wei Zheng; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs.

Authors:  Hyeung Kim; Ok-Hee Lee; Huawei Xin; Liuh-Yow Chen; Jun Qin; Heekyung Kate Chae; Shiaw-Yih Lin; Amin Safari; Dan Liu; Zhou Songyang
Journal:  Nat Struct Mol Biol       Date:  2009-03-15       Impact factor: 15.369

7.  The evaluation of hTERT mRNA expression in acute leukemia children and 2 years follow-up of 40 cases.

Authors:  Ozgur Cogulu; Buket Kosova; Cumhur Gunduz; Emin Karaca; Serap Aksoylar; Ayse Erbay; Deniz Karapinar; Canan Vergin; Filiz Vural; Murat Tombuloglu; Nazan Cetingul; Ferda Ozkinay
Journal:  Int J Hematol       Date:  2008-02-22       Impact factor: 2.490

8.  Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.

Authors:  Shi-Feng Xu; Zhi-Hai Peng; Da-Peng Li; Guo-Qiang Qiu; Fang Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Telomere shortening may be associated with human keloids.

Authors:  Bruna De Felice; Robert R Wilson; Massimo Nacca
Journal:  BMC Med Genet       Date:  2009-10-28       Impact factor: 2.103

10.  Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies.

Authors:  Ralf Hass; Catharina Bertram
Journal:  J Exp Clin Cancer Res       Date:  2009-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.